UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 644

Sortiert nach

Offline analysis of the relaxed upper boundedness for online estimation ofoptimal event sequences in Partially Observable Petri Nets

Discrete event dynamic systems, 2024, Vol.34 (2), p.351-374

Declerck, P.

2024

Link zum Volltext

Verfügbarkeit prüfen

Counter approach for the estimation of optimal sequences in Partially Observable Untimed Petri Nets

Discrete event dynamic systems, 2021-12, Vol.31 (4), p.489-512

Declerck, P.

2021

Link zum Volltext

Verfügbarkeit prüfen

Two-staged approach for estimation of sequences in partially observable P-time Petri nets on a sliding horizon with schedulability analysis

International journal of control, 2024-06, Vol.97 (6), p.1341-1350

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification of a bacterial inhibitor against g-type lysozyme

Cellular and molecular life sciences : CMLS, 2011-03, Vol.68 (6), p.1053-1064

2011

Link zum Volltext

Verfügbarkeit prüfen

Generation of a stable thrombin‐activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1084-1089

2015

Link zum Volltext

Verfügbarkeit prüfen

Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice

Journal of thrombosis and haemostasis, 2017-12, Vol.15 (12), p.2432-2442

2017

Link zum Volltext

Verfügbarkeit prüfen

Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin‐activatable fibrinolysis inhibitor activation and activated thrombin‐activatable fibrinolysis inhibitor activity

Journal of thrombosis and haemostasis, 2016-08, Vol.14 (8), p.1629-1638

2016

Link zum Volltext

Verfügbarkeit prüfen

Critical subsystems in time interval models: Application to a baking process

Discrete event dynamic systems, 2021-03, Vol.31 (1), p.25-35

Declerck, P.

2021

Link zum Volltext

Verfügbarkeit prüfen

Modelling Black Carbon concentrations in two busy street canyons in Brussels using CANSBC

Atmospheric environment (1994), 2015-01, Vol.101, p.72-81

2015

Link zum Volltext

Verfügbarkeit prüfen

Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.190-192

2013

Link zum Volltext

Verfügbarkeit prüfen

Development of a high throughput cross-flow filtration system for detailed investigation of fouling processes

Journal of membrane science, 2013-09, Vol.442, p.168-176

2013

Link zum Volltext

Verfügbarkeit prüfen

The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

The FASEB journal, 2002-02, Vol.16 (2), p.147-154

2002

Link zum Volltext

Verfügbarkeit prüfen

Biofouling on microfiltration membranes in MBRs: Role of membrane type and microbial community

Journal of membrane science, 2014-03, Vol.453, p.394-401

2014

Link zum Volltext

Verfügbarkeit prüfen

Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme

Cellular and molecular life sciences : CMLS, 2010-04, Vol.67 (7), p.1177-1188

2010

Link zum Volltext

Verfügbarkeit prüfen

The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency

Journal of thrombosis and haemostasis, 2012-12, Vol.10 (12), p.2555-2562

2012

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin‐activatable fibrinolysis inhibitor but not the anti‐inflammatory activity on osteopontin and C5a

Journal of thrombosis and haemostasis, 2013-12, Vol.11 (12), p.2137-2147

2013

Link zum Volltext

Verfügbarkeit prüfen

Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1302-1312

2010

Link zum Volltext

Verfügbarkeit prüfen

Thrombin activatable fibrinolysis inhibitor

Hämostaseologie, 2011, Vol.31 (3), p.165

Declerck, P J

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the profibrinolytic properties of a bispecific antibody‐based inhibitor against human and mouse thrombin‐activatable fibrinolysis inhibitor and plasminogen activator inhibitor‐1

Journal of thrombosis and haemostasis, 2013-11, Vol.11 (11), p.2069-2071

2013

Link zum Volltext

Verfügbarkeit prüfen

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Oncogene, 2004-09, Vol.23 (41), p.6986-6990

2004

Link zum Volltext

Verfügbarkeit prüfen

Critical subsystems in time interval models

Discrete event dynamic systems, 2021-01, Vol.31 (1), p.25-35

Declerck, P

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of a novel, nanobody‐induced, mechanism of TAFI inactivation and its in vivo application

Journal of thrombosis and haemostasis, 2014-02, Vol.12 (2), p.229-236

2014

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

British journal of cancer, 2000-05, Vol.82 (10), p.1702-1708

2000

Link zum Volltext

Verfügbarkeit prüfen

Systemic inhibition and liver‐specific over‐expression of PAI‐1 failed to improve survival in all‐inclusive populations or homogenous cohorts of CLP mice

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.958-969

2014

Link zum Volltext

Verfügbarkeit prüfen

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study

Journal of thrombosis and haemostasis, 2009-06, Vol.7 (6), p.919-927

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 644

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(548)
Mit Volltextzugriff
(533)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(436)
Life Sciences & Biomedicine
(386)
Humans
(271)
Biological And Medical Sciences
(174)
Animals
(114)
Female
(113)
Medical Sciences
(108)
Male
(102)
Hematology
(89)
Cardiovascular System & Cardiology
(85)
Biochemistry & Molecular Biology
(78)
Peripheral Vascular Disease
(75)
Fundamental And Applied Biological Sciences. Psychology
(73)
Middle Aged
(71)
Adult
(69)
Technology
(53)
Fibrinolysis
(49)
Mice
(42)
Aged
(38)
Physical Sciences
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Offline analysis of the relaxed upper boundedness for online estimation ofoptimal event sequences in Partially Observable Petri Nets

Counter approach for the estimation of optimal sequences in Partially Observable Untimed Petri Nets

Two-staged approach for estimation of sequences in partially observable P-time Petri nets on a sliding horizon with schedulability analysis

Identification of a bacterial inhibitor against g-type lysozyme

Generation of a stable thrombin‐activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation

Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice

Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin‐activatable fibrinolysis inhibitor activation and activated thrombin‐activatable fibrinolysis inhibitor activity

Critical subsystems in time interval models: Application to a baking process

Modelling Black Carbon concentrations in two busy street canyons in Brussels using CANSBC

Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi

Development of a high throughput cross-flow filtration system for detailed investigation of fouling processes

The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

Biofouling on microfiltration membranes in MBRs: Role of membrane type and microbial community

Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme

The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency

Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin‐activatable fibrinolysis inhibitor but not the anti‐inflammatory activity on osteopontin and C5a

Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor

Thrombin activatable fibrinolysis inhibitor

Evaluation of the profibrinolytic properties of a bispecific antibody‐based inhibitor against human and mouse thrombin‐activatable fibrinolysis inhibitor and plasminogen activator inhibitor‐1

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Critical subsystems in time interval models

Identification of a novel, nanobody‐induced, mechanism of TAFI inactivation and its in vivo application

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

Systemic inhibition and liver‐specific over‐expression of PAI‐1 failed to improve survival in all‐inclusive populations or homogenous cohorts of CLP mice

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study

Suchergebnisse filtern